Matches in Wikidata for { <http://www.wikidata.org/entity/Q91821170> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q91821170 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91821170 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91821170 description "scientific article published on 28 November 2019" @default.
- Q91821170 description "wetenschappelijk artikel" @default.
- Q91821170 description "наукова стаття, опублікована 28 листопада 2019" @default.
- Q91821170 name "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 name "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 type Item @default.
- Q91821170 label "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 label "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 prefLabel "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 prefLabel "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 P1433 Q91821170-BFA4CD97-BA55-4357-BC97-3E1B2CFDCC1D @default.
- Q91821170 P1476 Q91821170-B24B4620-40ED-42EB-88AB-EAE2EEFF2C0F @default.
- Q91821170 P2093 Q91821170-0D1F1794-99EB-4212-A2AE-4A31F885683A @default.
- Q91821170 P2093 Q91821170-2CF057BB-180A-4D55-8478-15DABD91CFF9 @default.
- Q91821170 P2093 Q91821170-473335EF-B30C-4E4F-ABDF-B06BBA162A8F @default.
- Q91821170 P31 Q91821170-986CF332-D0F1-40E0-B2C3-0FD729EBBF0D @default.
- Q91821170 P356 Q91821170-B6E104CA-2D99-4D7D-A6F3-7E29C0F223F5 @default.
- Q91821170 P50 Q91821170-91EE152D-2AB4-4D9B-ABFA-6373920DCAC3 @default.
- Q91821170 P577 Q91821170-BC7D2CD0-F881-4A86-83B8-B8F5715C0A2A @default.
- Q91821170 P698 Q91821170-7F881E3B-3386-4DF2-A38A-5A8B906A4A97 @default.
- Q91821170 P921 Q91821170-52271FCF-0252-405A-B756-64394A73373B @default.
- Q91821170 P921 Q91821170-E0B1B763-86DE-4934-A655-1D5B230BF6CC @default.
- Q91821170 P356 J.CLNU.2019.11.032 @default.
- Q91821170 P698 31818531 @default.
- Q91821170 P1433 Q15764056 @default.
- Q91821170 P1476 "Effect of α-linolenic acid on vascular function and metabolic risk markers during the fasting and postprandial phase: A randomized placebo-controlled trial in untreated (pre-)hypertensive individuals" @default.
- Q91821170 P2093 "Dagmar Fuchs" @default.
- Q91821170 P2093 "Peter J Joris" @default.
- Q91821170 P2093 "Richard Draijer" @default.
- Q91821170 P31 Q13442814 @default.
- Q91821170 P356 "10.1016/J.CLNU.2019.11.032" @default.
- Q91821170 P50 Q92464699 @default.
- Q91821170 P577 "2019-11-28T00:00:00Z" @default.
- Q91821170 P698 "31818531" @default.
- Q91821170 P921 Q108853737 @default.
- Q91821170 P921 Q269829 @default.